HIVNET at the 12th World AIDS Conference -- Geneva, Switzerland

http://www.aids98.ch

The 12th World AIDS Conference in Geneva, Switzerland (28 June 28 - 3 July 1998) was the site of a number of presentations by HIVNET investigators and staff. The data presented came from three HIVNET studies: the Vaccine Preparedness Study, a Phase II vaccine trial, and a safety study of a vaginal microbicide.

For further information on all of the abstracts presented at the 12th World AIDS Conference, visit the website for Marathon Multimedia.

Abstracts:

• Retention of (HIV-) High Risk Women Enrolled in the HIVNET Vaccine Preparedness Study (Affleck, Patricia)
  
  
• Enabling Women to Participate in HIV Vaccine Efficacy Trials: Lessons Learned from a U.S. Vaccine Preparedness Study (Brown-Peterside, Pamela)
  
  
• Risk Behaviors Reported by Newly Infected Men Who Have Sex With Men (MSM): Implications for Prevention Intervention (Buchbinder, Susan)
  
  
• Risk Factors for HIV seroconversion in a Contemporary Cohort of High Risk Men Who Have Sex with Men (MSM) (Buchbinder, Susan)
  
  
• Characteristics of Incidence Seroconverters and their Predominant Viral Type: Findings from a Population-Based Cohort (Celum, Connie)
  
  
• Plasma and Genital Tract Viral Load and STDs in Early HIV Infection (Celum, Connie)
  
  
• Real Experience: The Key to Vaginal Micorobicide Acceptability (Chesney, Margaret)
  
  
• Randomized, Controlled Evaluation of a Prototype Informed Consent Process for HIV Vaccine Efficacy Trials (Coletti, Anne)
  
  
• Oral Chemoprophylaxsis to Prevent HIV Infection: Attitudes and Interest Among High Risk HIV-Negative US Populations (Gross, Michael)
  
  
• Use of Reality® Condoms for Anal Sex by HIV-Seronegative US Gay/Bisexual Men at Increased Risk of HIV Infection (Gross, Michael)
  
  
• Douching Practices Among U.S. Women at High Risk of HIV Infection, Vaccine Preparedness Study of HIVNET (Koblin, Beryl)
  
  
• HIV Risk Behaviors Among Women Who Have Sex With Women (WSWs) Enrolled in a High-Risk US Cohort (Marmor, Michael)
  
  
• BufferGel: Results of the First Phase I Study of Novel Vaginal Microbicide (Mayer, Kenneth)
  
  
• Feasibility of Conducting HIV-1 Vaccine Trials in the United States: Recruitment, Retention and HIV-1 Seroincidence from the HIV Network for Prevention Trials (HIVNET) Vaccine Preparedness Study (VPS) (Seage, George)
  
  
• Secondary Traumatic Stress Syndrome: Understandings and Coping Mechanisms Learned During HIV Prevention Research at the University of Illinois at Chicago (Smith, Carrol)
  
  
• Home Specimen Collection for Early Detection of HIV: Feasibility & Acceptability Among Those at Risk (Spielberg, Freya)
  
  
• Cross-Clade Envelope Gp160, Gag p55 and Pol Specific CD8+ CTL Responses Early Following HIV-1 Clade-B Infection (Wilson, Susan)
  
  
• Videotape in a Vaccine Education Initiative (Workman, Joy)
  
  
• Asking for Community Assistance to Prepare for Large HIV Vaccine Trials in San Francisco (Wright, Joe)